Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Clinical and pathologic features of cardiac hemochromatosis diagnosed by endomyocardial biopsy in six men, aged 32 to 75 years (mean 52), are described. Echocardiography demonstrated left ventricular enlargement and marked global systolic dysfunction in five. Cardiac catheterization demonstrated normal coronary arteries, increased left ventricular end-diastolic pressure and decreased left ventricular systolic function in all five so studied. Stainable iron was present in all endomyocardial biopsy specimens from the five patients with decreased left ventricular systolic function. Histologically, iron was detected only within the sarcoplasm, and its extent varied inversely with ventricular function. Thus, cardiac hemochromatosis represents a storage rather than an infiltrative disease. These results indicate that stainable iron is consistently observed in endomyocardial biopsy specimens from patients with impaired left ventricular systolic function. Iron staining is recommended for endomyocardial biopsy specimens from patients with idiopathic cardiac dysfunction.

This article has been cited by other articles:

				J.-P. Carpenter, T. He, P. Kirk, M. Roughton, L. J. Anderson, S. V. de Noronha, M. N. Sheppard, J. B. Porter, J. M. Walker, J. C. Wood, et al. On T2* Magnetic Resonance and Cardiac Iron Circulation, April 12, 2011; 123(14): 1519 - 1528. [Abstract] [Full Text] [PDF]

				P. Gujja, D. R. Rosing, D. J. Tripodi, and Y. Shizukuda Iron Overload Cardiomyopathy: Better Understanding of an Increasing Disorder J. Am. Coll. Cardiol., September 21, 2010; 56(13): 1001 - 1012. [Abstract] [Full Text] [PDF]

				A Pepe, V Positano, M Capra, A Maggio, C L Pinto, A Spasiano, G Forni, G Derchi, B Favilli, G Rossi, et al. Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major Heart, October 15, 2009; 95(20): 1688 - 1693. [Abstract] [Full Text] [PDF]

				Y. Nagayoshi, M. Nakayama, S. Suzuki, J. Hokamaki, H. Shimomura, K. Tsujita, M. Fukuda, T. Yamashita, Y. Nakamura, S. Sugiyama, et al. A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis Eur J Heart Fail, October 1, 2008; 10(10): 1001 - 1006. [Abstract] [Full Text] [PDF]

				E. S. Davidsen, K. Liseth, P. Omvik, T. Hervig, and E. Gerdts Reduced exercise capacity in genetic haemochromatosis European Journal of Cardiovascular Prevention & Rehabilitation, June 1, 2007; 14(3): 470 - 475. [Abstract] [Full Text] [PDF]

				J. Kilo, G. Laufer, and H. Antretter Endomyocardial biopsy - jugular/subclavian vein approach MMCTS, January 1, 2006; 2006(1110): mmcts.2005.001149 - mmcts.2005.001149. [Abstract] [Full Text] [PDF]

				J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, H. Pollack, and R. Moats Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy Circulation, July 26, 2005; 112(4): 535 - 543. [Abstract] [Full Text] [PDF]

				S. Seth, D. Thatai, S. Sharma, P. Chopra, and K.K. Talwar Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India Eur J Heart Fail, October 1, 2004; 6(6): 723 - 729. [Abstract] [Full Text] [PDF]

				P. D. Jensen, F. T. Jensen, T. Christensen, H. Eiskjaer, U. Baandrup, and J. L. Nielsen Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool Blood, June 1, 2003; 101(11): 4632 - 4639. [Abstract] [Full Text] [PDF]